NCT05390138

Brief Summary

OSA is a chronic disease with high prevalence that parallels with increasing obesity. Self-management programmes are perceived to be cost-effective in long-term OSA patient care and can supplement regular medical treatments. The current study attempt to examine the effectiveness of 4S on improving apnea severity, cardiovascular health and quality of life in 4S intervention (4S) group, compared to the general hygiene (GH) control group.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

May 25, 2022

Status Verified

May 1, 2022

Enrollment Period

2.3 years

First QC Date

April 21, 2022

Last Update Submit

May 23, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in apnea hypopnea index

    Apnea hypopnea index will be asssessed by sleep test. The apnea hypopnea index is the number of times of apnea or hypopnea during one night, divided by the hours of sleep. The higher the apnea hypopnea index, the more severe sleep apnea is.

    Baseline, 4 months

Secondary Outcomes (26)

  • Change in apnea hypopnea index

    Baseline and 12 months

  • Change in Duration of <90% oxygen desaturation

    Baseline, 4 months and 12 months

  • Change in body weight

    Baseline, 4 months and 12 months

  • Change in body fat

    Baseline, 4 months and 12 months

  • Change in body neck circumference

    Baseline, 4 months and 12 months

  • +21 more secondary outcomes

Study Arms (2)

Smart Sleep Apnea Self-management Support Programme (4S)

EXPERIMENTAL

Patients will receive Smart Sleep Apnea Self-management Support Programme (4S) in addition to usual care

Behavioral: Smart Sleep Apnea Self-management Support Programme (4S)

General Hygiene Information (GH)

PLACEBO COMPARATOR

Patients will receive general hygiene information (GH) in addition to usual care

Behavioral: General Hygiene Information (GH)

Interventions

The experimental group will receive usual care and Smart Sleep Apnea Self-management Support Programme (4S). The 4S includes two interview sessions, instant messages, phone calls, continuous personalized chat-based messaging and phone call support and hotline services in relation to self-management. An e-platform will be used for self-monitoring and group sharing sessions will be conducted for experience sharing.

Also known as: 4S group
Smart Sleep Apnea Self-management Support Programme (4S)

The control group will receive usual care and general hygiene information (GH). The GH includes two GH sessions, instant messages, phone calls, continuous personalized chat-based messaging and phone call support and hotline services in relation to general hygiene information. An e-platform will be used for self-monitoring and group sharing sessions will be conducted for experience sharing.

Also known as: GH group
General Hygiene Information (GH)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 years and above;
  • diagnosis of moderate to severe obstructive sleep apnea (AHI≥15);
  • physically inactive (self-reported moderate physical activity per week of \<150 minutes);
  • overweight (BMI≥23 kg/m2);
  • mentally, cognitively and physically fit to join the trial as determined by the doctor in-charge and responsible clinical investigators;
  • able to speak and read Chinese;
  • willing to complete the questionnaires and assessments;
  • has a smartphone with instant messaging function (eg. WhatsApp/WeChat); and
  • willing to give informed consent.

You may not qualify if:

  • sleep disorder other than OSA;
  • clinically significant psychiatric, neurological, or medical disorder other than OSA; and
  • use of prescription drugs or clinically significant drugs affecting sleep.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (10)

  • Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pepin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9.

    PMID: 31300334BACKGROUND
  • Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009 Jun 15;5(3):263-76.

    PMID: 19960649BACKGROUND
  • Andrade FM, Pedrosa RP. The role of physical exercise in obstructive sleep apnea. J Bras Pneumol. 2016 Nov-Dec;42(6):457-464. doi: 10.1590/S1806-37562016000000156.

    PMID: 28117479BACKGROUND
  • Iftikhar IH, Kline CE, Youngstedt SD. Effects of exercise training on sleep apnea: a meta-analysis. Lung. 2014 Feb;192(1):175-84. doi: 10.1007/s00408-013-9511-3.

    PMID: 24077936BACKGROUND
  • Aiello KD, Caughey WG, Nelluri B, Sharma A, Mookadam F, Mookadam M. Effect of exercise training on sleep apnea: A systematic review and meta-analysis. Respir Med. 2016 Jul;116:85-92. doi: 10.1016/j.rmed.2016.05.015. Epub 2016 May 21.

    PMID: 27296826BACKGROUND
  • Stepnowsky CJ, Palau JJ, Gifford AL, Ancoli-Israel S. A self-management approach to improving continuous positive airway pressure adherence and outcomes. Behav Sleep Med. 2007;5(2):131-46. doi: 10.1080/15402000701190622.

    PMID: 17441783BACKGROUND
  • Dickerson SS, Jungquist C, TenBrock E, Aquilina A, Smith P, Sabbah EA, Alameri R, Dean G. Feasibility Testing of a Self-Management Program Book to Improve Adherence to PAP in Persons Newly Diagnosed With Sleep Apnea. Behav Sleep Med. 2018 Sep-Oct;16(5):413-426. doi: 10.1080/15402002.2016.1228644. Epub 2016 Sep 23.

    PMID: 27660897BACKGROUND
  • Dickerson SS, TenBrock E, Smith P, Kwon M, Chacko T, Li CS, Dean GE. Mixed methods feasibility study of Breathe2Sleep a peer modeling approach to PAP self-management. Heart Lung. 2020 Nov-Dec;49(6):949-958. doi: 10.1016/j.hrtlng.2020.04.015. Epub 2020 May 28. No abstract available.

    PMID: 32473747BACKGROUND
  • Zimbudzi E, Lo C, Misso ML, Ranasinha S, Kerr PG, Teede HJ, Zoungas S. Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis. Syst Rev. 2018 Jun 13;7(1):84. doi: 10.1186/s13643-018-0748-z.

    PMID: 29898785BACKGROUND
  • Suarez-Giron M, Garmendia O, Lugo V, Ruiz C, Salord N, Alsina X, Farre R, Montserrat JM, Torres M. Mobile health application to support CPAP therapy in obstructive sleep apnoea: design, feasibility and perspectives. ERJ Open Res. 2020 Feb 10;6(1):00220-2019. doi: 10.1183/23120541.00220-2019. eCollection 2020 Jan.

    PMID: 32055630BACKGROUND

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Agnes YK Lai, PhD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agnes YK Lai, PhD

CONTACT

George Cheung, MPhil

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor did not aware of which groups the patients belongs to.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a 2-group randomisation controlled trial with 4-month and 12-month follow-up. The Experimental group will receive 4S intervention in relation to self-management and the Control group will receive general hygiene information.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 21, 2022

First Posted

May 25, 2022

Study Start

June 1, 2022

Primary Completion

September 20, 2024

Study Completion

December 20, 2024

Last Updated

May 25, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

Need to obtain consent from patients before agreeing to share individual participants data.

Shared Documents
STUDY PROTOCOL
Time Frame
When study finished
Access Criteria
The minimal anonymized dataset will be available upon request to interested researchers. For interested researchers, please contact, Mr George Cheung (email ocgeorge@hku.hk), (School of Nursing, The University of Hong Kong) for further information.